FDA Alert: Dietary Supplement Recalled for Containing Prescription Drug Ingredients

February 26, 2025

This is a reprint of an FDA Alert. One Source Nutrition, Inc. Issues Voluntary Nationwide Recall of Vitality Capsules Due to Presence of Undeclared Sildenafil and Tadalafil When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does not endorse either the product…

Read More

February 24, 2025: PSM report finds 80% of declared, unapproved semaglutide and tirzepatide slipped past customs over 17 months

February 25, 2025

PSM’s new report shows that unregulated semaglutide and tirzepatide are slipping by FDA and CBP at the border. Semaglutide is no longer in shortage.

Read More

New report reveals illegal ingredients for knockoff weight loss drugs flooding into U.S. from foreign sources, endangering patient safety

February 20, 2025

The Partnership for Safe Medicines today released a new report that found suspicious, unauthorized, and illegal ingredients for popular diabetes and obesity injectables (commonly known as weight loss drugs) are flooding into the U.S. from foreign sources despite U.S. laws forbidding them from coming through the border.

Read More

PSM applauds Arkansas Board of Pharmacy for protecting patients

February 14, 2025

The Partnership for Safe Medicines applauds the Arkansas State Board of Pharmacy for utilizing new product verification technology for identifying illegitimate Ozempic quarantined by a pharmacy this week.

Read More
A woman's neck frings with layers of red welts

February 10, 2025: NY woman allegedly injected mystery substances instead of Botox

February 10, 2025

Mystery cosmetic injections allegedly harmed a client in Queens. PSM addressed a misleading drug ad for compounded weight loss medicine.

Read More

Over 100 million Americans just watched a misleading ad at the Super Bowl.

February 9, 2025

You could tell an American that they’re getting a compounded medicine and they would have no idea what that meant.  That may be a legal disclosure, but that’s not good enough to protect patients who don’t know what the words mean.

Read More

Letter to FDA’s Office of Prescription Drug Promotion, CDER

February 5, 2025

PSM sent the following letter to the FDA’s Office of Prescription Drug Promotion (CDER) asking them to enforce the laws and guidelines that protect Americans from misleading advertising in the Hims&Hers Super Bowl ad.

Read More

Letter to Fox Corporation regarding misleading Hims & Hers Super Bowl ad

February 5, 2025

PSM sent the attached letter to Fox Broadcasting, calling on them to withdraw the deeply troubling and misleading Hims&Hers Super Bowl ad.

Read More

February 3, 2025: A New York jury convicts precursor sellers

February 3, 2025

Employees of the now-closed Chinese chemical company Hubei Amarvel Biotech were convicted at trial after shipping more than 200 kilograms of fentanyl precursor chemicals to the U.S. between November 2022 and June 2023.

Read More

Partnership for Safe Medicines statement on weight loss drug ad blitz

February 3, 2025

Partnership for Safe Medicines released the following statement in response to the advertisement that lifestyle brand Hims & Hers released ahead of the Super Bowl to sell unregulated compounded weight loss drugs

Read More